- Home
- EOSEW vs IDYA Comparison
EOSEW vs IDYA Comparison
Compare EOSEW & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOSEW
- IDYA
- Stock Information
- Founded
- EOSEW N/A
- IDYA 2015
- Country
- EOSEW United States
- IDYA United States
- Employees
- EOSEW 420
- IDYA N/A
- Industry
- EOSEW Industrial Machinery/Components
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- EOSEW Miscellaneous
- IDYA Health Care
- Exchange
- EOSEW Nasdaq
- IDYA Nasdaq
- Market Cap
- EOSEW N/A
- IDYA 2.6B
- IPO Year
- EOSEW N/A
- IDYA 2019
- Fundamental
- Price
- EOSEW $0.21
- IDYA $30.82
- Analyst Decision
- EOSEW
- IDYA Strong Buy
- Analyst Count
- EOSEW 0
- IDYA 10
- Target Price
- EOSEW N/A
- IDYA $56.00
- AVG Volume (30 Days)
- EOSEW N/A
- IDYA 1.0M
- Earning Date
- EOSEW N/A
- IDYA 11-05-2024
- Dividend Yield
- EOSEW N/A
- IDYA N/A
- EPS Growth
- EOSEW N/A
- IDYA N/A
- EPS
- EOSEW N/A
- IDYA N/A
- Revenue
- EOSEW N/A
- IDYA $11,961,000.00
- Revenue This Year
- EOSEW N/A
- IDYA N/A
- Revenue Next Year
- EOSEW N/A
- IDYA $94.96
- P/E Ratio
- EOSEW N/A
- IDYA N/A
- Revenue Growth
- EOSEW N/A
- IDYA N/A
- 52 Week Low
- EOSEW N/A
- IDYA $23.41
- 52 Week High
- EOSEW N/A
- IDYA $47.74
- Technical
- Relative Strength Index (RSI)
- EOSEW 50.60
- IDYA 42.69
- Support Level
- EOSEW $0.17
- IDYA $28.69
- Resistance Level
- EOSEW $0.24
- IDYA $31.54
- Average True Range (ATR)
- EOSEW 0.04
- IDYA 1.32
- MACD
- EOSEW -0.00
- IDYA 0.23
- Stochastic Oscillator
- EOSEW 67.57
- IDYA 67.62
About EOSEW Eos Energy Enterprises Inc. Warrant
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.